Choosing the Best Health Risk Assessment

| April 3, 2018

article image
The Health Risk Assessment (HRA) is a beneficial first step in laying the foundation of a good employee wellness the program, a personalized prevention plan, or population health management. A well-designed HRA helps individuals get a good picture of their health status and future quality of life by making the connection between lifestyle habits and the risk for chronic disease.

Spotlight

Asian Pharmaceuticals Private LTD

Asian Pharmaceuticals Pvt. Ltd. is a renowned manufacturer of a broad range of prescription and non-prescription drugs in Nepal. Established in 2055 B.S. (1998 AD), Asian Pharmaceuticals Pvt. Ltd. is founded on a deep sense of National Pride and the conviction to make a contribution to our country's self-reliance in the field of Pharmaceutical formulations

OTHER ARTICLES

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 26, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Comparing HydroxyChloroquine Trials

Article | March 26, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 26, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Spotlight

Asian Pharmaceuticals Private LTD

Asian Pharmaceuticals Pvt. Ltd. is a renowned manufacturer of a broad range of prescription and non-prescription drugs in Nepal. Established in 2055 B.S. (1998 AD), Asian Pharmaceuticals Pvt. Ltd. is founded on a deep sense of National Pride and the conviction to make a contribution to our country's self-reliance in the field of Pharmaceutical formulations

Events